BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25592378)

  • 1. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
    Song GD; Sun Y; Shen H; Li W
    Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
    Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
    Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RLIP76 expression as a prognostic marker of breast cancer.
    Wang CZ; Yuan P; Xu B; Yuan L; Yang HZ; Liu X
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2105-11. PubMed ID: 26125275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer.
    Huang R; Huang D; Dai W; Yang F
    Mol Cell Biochem; 2015 Jun; 404(1-2):251-7. PubMed ID: 25772486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and prognostic significance of midkine in breast cancer patients.
    Li F; Tian P; Zhang J; Kou C
    Tumour Biol; 2015 Dec; 36(12):9789-94. PubMed ID: 26159850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
    Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
    BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of transcription factor SOX4 and its clinical significance in female lung cancer patients in Xuanwei area, Yunnan Province].
    Zhou YC; Wang XC; Chen Y; Zhang LJ; Liu X; Yao Q; Chen XQ; Zhao GQ; Huang YC
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):202-6. PubMed ID: 23880001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
    Pang EJ; Yang R; Fu XB; Liu YF
    Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of SOX4 is associated with colorectal cancer progression.
    Wang B; Li Y; Tan F; Xiao Z
    Tumour Biol; 2016 Jul; 37(7):9131-7. PubMed ID: 26768610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma.
    Zhang H; Zhao L; Wang YX; Xi M; Liu SL; Luo LL
    Tumour Biol; 2015 Nov; 36(11):8805-9. PubMed ID: 26058875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis.
    Chen J; Ju HL; Yuan XY; Wang TJ; Lai BQ
    Clin Transl Oncol; 2016 Jan; 18(1):65-72. PubMed ID: 26250764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro.
    Wang L; Zhang J; Yang X; Chang YW; Qi M; Zhou Z; Zhang J; Han B
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):301-7. PubMed ID: 23917306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
    Zhang Z; Wang Q; Chen F; Liu J
    Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
    Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
    Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma.
    Lu N; Lin T; Wang L; Qi M; Liu Z; Dong H; Zhang X; Zhai C; Wang Y; Liu L; Xiang L; Qi L; Han B; Li J
    Tumour Biol; 2015 May; 36(5):3843-52. PubMed ID: 25572678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2.
    Song Z; Zhang X; Lin Y; Wei Y; Liang S; Dong C
    J Cell Mol Med; 2019 Nov; 23(11):7554-7565. PubMed ID: 31557401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.
    Ren YK; Xiao Y; Wan XB; Zhao YZ; Li J; Li Y; Han GS; Chen XB; Zou QY; Wang GC; Lu CM; Xu YC; Wang YC
    Int J Clin Exp Pathol; 2015; 8(9):11458-63. PubMed ID: 26617875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer.
    Lin CM; Fang CL; Hseu YC; Chen CL; Wang JW; Hsu SL; Tu MD; Hung ST; Tai C; Uen YH; Lin KY
    PLoS One; 2013; 8(6):e67128. PubMed ID: 23826209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.